Rockefeller Capital Management L.P. Spring Works Therapeutics, Inc. Transaction History
Rockefeller Capital Management L.P.
- $34.7 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$225 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$193 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$127 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$124 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$118 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.15B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...